Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Janus kinase inhibitors in autoimmune bullous diseases
Dawei Huang, Yuexin Zhang, Luyang Kong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17

Showing 17 citing articles:

Bullous pemphigoid
Hossein Akbarialiabad, Enno Schmidt, Aikaterini Patsatsi, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 1
Long-term efficacy and safety of dupilumab for severe bullous pemphigoid: A prospective cohort study
Dawei Huang, Yuexin Zhang, Yingyuan Yu, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111157-111157
Open Access | Times Cited: 10
Bullous Pemphigoid: A practical approach to diagnosis and management in the modern era
Camille M. Powers, Sach Thakker, Nicholas Gulati, et al.
Journal of the American Academy of Dermatology (2025)
Closed Access
Treatment of Synovitis, Acne, Pustulosis, Hyperstosis, and Osteitis Syndrome With Abrocitinib
Dawei Huang, Yujing Zhao, Yuling Shi, et al.
JAMA Dermatology (2025)
Closed Access
Janus Kinase Inhibitors in the Treatment of Refractory Cicatrizing Conjunctivitis in Pemphigoid
Celine Nguyen, Ebuka Eziama, Arturo R. Domínguez, et al.
The Ocular Surface (2025)
Closed Access
Refractory Hailey–Hailey disease cleared with upadacitinib
Lauren Murphy, Peter Ch’en, Eingun James Song
JAAD Case Reports (2023) Vol. 41, pp. 64-67
Open Access | Times Cited: 8
Remission of refractory esophageal lichen planus induced by tofacitinib
Valentina Bieneck, Annegrit Decker, Annette Schmitt‐Graeff, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 09, pp. 1384-1388
Open Access | Times Cited: 2
Upadacitinib leading to resolution of refractory mucosal erosions in a case of pemphigus vulgaris
M. Grace Hren, Saakshi Khattri
International Journal of Dermatology (2024)
Open Access | Times Cited: 2
2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4H-Chromen-4-One Flavones Based Virtual Screening for Potential JAK Inhibitors in Inflammatory Disorders
Sumit Deore, Pravin Tajane, Avinash Bhosale, et al.
International Research Journal of Multidisciplinary Scope (2024) Vol. 05, Iss. 01, pp. 557-567
Open Access | Times Cited: 1
Single-cell sequencing reveals distinct immune cell features in cutaneous lesions of pemphigus vulgaris and bullous pemphigoid
Zhi Hu, Meiling Zheng, Ziyu Guo, et al.
Clinical Immunology (2024) Vol. 263, pp. 110219-110219
Closed Access | Times Cited: 1
A successful experience in treating lichen planus pemphigoides with tofacitinib: a case report
Kamran Balighi, Amirhossein Sharifi, Kambiz Kamyab Hesari, et al.
International Journal of Dermatology (2024)
Closed Access | Times Cited: 1
Bullous pemphigoid treated with baricitinib as steroid-sparing therapy for a patient with uncontrolled diabetes
Junyoung Heo, Youngkyoung Lim
JAAD Case Reports (2024) Vol. 57, pp. 5-8
Open Access | Times Cited: 1
Baricitinib as a treatment for recalcitrant paraneoplastic pemphigus in a young child
Henrietta Albela, Nur Syazwin Sies, Lee Tyan Shin, et al.
International Journal of Dermatology (2024) Vol. 63, Iss. 12
Closed Access
The effectiveness of ruxolitinib and cyclophosphamide combination on T helper 17 and regulatory T cells in rat experimental membranous glomerulonephritis
Rahim Iranzad, Maryam Hosseini, Mahdi Bagheri, et al.
Molecular and Cellular Probes (2024) Vol. 76, pp. 101969-101969
Open Access
Treatment of pemphigus foliaceus with upadacitinib
Efthymia Soura, Maria Gerochristou, Τheodora Douvali, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access
Rapid and Sustained Improvement of Lichen Planus Pemphigoides With the JAK1 Inhibitor Upadacitinib
Louise Gueissaz, Ronald Wolf, Christoph Schlapbach
JEADV Clinical Practice (2024)
Open Access
Effective Response of Pemphigus Erythematosus to Treatment With Baricitinib
Xinyi Chen, Yunlei Pan, Xinxing Jin, et al.
American Journal of Therapeutics (2024)
Closed Access
Page 1

Scroll to top